Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Stem Cells | 16 | 2025 | 203 | 5.430 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 17 | 2019 | 68 | 4.940 |
Why?
|
| Fusion Proteins, bcr-abl | 8 | 2019 | 32 | 1.220 |
Why?
|
| Stem Cells | 2 | 2025 | 258 | 1.010 |
Why?
|
| Leukemia | 1 | 2025 | 54 | 0.960 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 173 | 0.800 |
Why?
|
| Polycythemia Vera | 2 | 2025 | 6 | 0.790 |
Why?
|
| Janus Kinase 2 | 2 | 2025 | 15 | 0.790 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2025 | 275 | 0.750 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2016 | 170 | 0.750 |
Why?
|
| Arachidonate 5-Lipoxygenase | 3 | 2016 | 11 | 0.740 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2010 | 83 | 0.740 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 65 | 0.690 |
Why?
|
| Lymph Nodes | 1 | 2020 | 215 | 0.670 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 194 | 0.670 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2020 | 168 | 0.650 |
Why?
|
| Mice | 18 | 2025 | 10317 | 0.620 |
Why?
|
| src-Family Kinases | 3 | 2013 | 60 | 0.600 |
Why?
|
| Benzamides | 7 | 2014 | 51 | 0.570 |
Why?
|
| Piperazines | 7 | 2014 | 81 | 0.560 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2012 | 73 | 0.560 |
Why?
|
| Pyrimidines | 7 | 2014 | 124 | 0.550 |
Why?
|
| Imatinib Mesylate | 8 | 2019 | 33 | 0.540 |
Why?
|
| Animals | 20 | 2025 | 19739 | 0.530 |
Why?
|
| Membrane Proteins | 2 | 2012 | 847 | 0.490 |
Why?
|
| Protein Kinase Inhibitors | 7 | 2019 | 171 | 0.480 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2019 | 184 | 0.470 |
Why?
|
| Mice, Knockout | 7 | 2016 | 1995 | 0.470 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 646 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 7 | 2016 | 3215 | 0.400 |
Why?
|
| Antigens, Ly | 1 | 2012 | 40 | 0.400 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2012 | 32 | 0.400 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2012 | 9 | 0.400 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 31 | 0.380 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2011 | 5 | 0.380 |
Why?
|
| Signal Transduction | 6 | 2022 | 2892 | 0.370 |
Why?
|
| Cell Lineage | 1 | 2012 | 250 | 0.360 |
Why?
|
| Hypoxia | 1 | 2012 | 109 | 0.360 |
Why?
|
| Cell Cycle | 2 | 2013 | 382 | 0.360 |
Why?
|
| Disease Models, Animal | 4 | 2016 | 2074 | 0.350 |
Why?
|
| Apoptosis | 2 | 2012 | 1042 | 0.340 |
Why?
|
| Myeloproliferative Disorders | 1 | 2009 | 15 | 0.340 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2010 | 112 | 0.320 |
Why?
|
| Humans | 16 | 2025 | 60081 | 0.260 |
Why?
|
| HSP90 Heat-Shock Proteins | 3 | 2012 | 67 | 0.250 |
Why?
|
| Carrier Proteins | 1 | 2009 | 703 | 0.240 |
Why?
|
| Hydroxyurea | 2 | 2016 | 22 | 0.220 |
Why?
|
| Blotting, Western | 2 | 2016 | 592 | 0.210 |
Why?
|
| Flow Cytometry | 2 | 2016 | 638 | 0.200 |
Why?
|
| Oxidative Phosphorylation | 1 | 2022 | 35 | 0.200 |
Why?
|
| K562 Cells | 2 | 2012 | 58 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 2 | 2016 | 876 | 0.190 |
Why?
|
| Genes, abl | 2 | 2012 | 9 | 0.190 |
Why?
|
| Hematoxylin | 1 | 2020 | 11 | 0.180 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2020 | 12 | 0.180 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2011 | 46 | 0.180 |
Why?
|
| Coloring Agents | 1 | 2020 | 54 | 0.180 |
Why?
|
| 5-Lipoxygenase-Activating Proteins | 2 | 2010 | 2 | 0.170 |
Why?
|
| Lipoxygenase Inhibitors | 2 | 2010 | 6 | 0.170 |
Why?
|
| Microscopy | 1 | 2020 | 88 | 0.170 |
Why?
|
| Transplantation, Heterologous | 2 | 2011 | 225 | 0.170 |
Why?
|
| Staining and Labeling | 1 | 2020 | 125 | 0.170 |
Why?
|
| Thiazolidines | 1 | 2019 | 15 | 0.160 |
Why?
|
| Biphenyl Compounds | 1 | 2019 | 29 | 0.160 |
Why?
|
| Biopsy | 1 | 2020 | 375 | 0.160 |
Why?
|
| Cell Proliferation | 3 | 2014 | 944 | 0.160 |
Why?
|
| Feasibility Studies | 1 | 2020 | 531 | 0.150 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 118 | 0.150 |
Why?
|
| Gene Expression Profiling | 2 | 2012 | 713 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 908 | 0.150 |
Why?
|
| Hospitals | 1 | 2020 | 377 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 317 | 0.140 |
Why?
|
| Research | 1 | 2019 | 190 | 0.140 |
Why?
|
| Leukotriene Antagonists | 1 | 2016 | 9 | 0.140 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2016 | 26 | 0.140 |
Why?
|
| Ceramides | 1 | 2016 | 25 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2011 | 2095 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 448 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 492 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2013 | 7 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2013 | 9 | 0.110 |
Why?
|
| GA-Binding Protein Transcription Factor | 1 | 2013 | 16 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2014 | 365 | 0.100 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2012 | 16 | 0.100 |
Why?
|
| PAX5 Transcription Factor | 1 | 2012 | 12 | 0.100 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 1 | 2012 | 3 | 0.100 |
Why?
|
| Survival Analysis | 2 | 2014 | 558 | 0.100 |
Why?
|
| Gamma Rays | 1 | 2012 | 31 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 30 | 0.100 |
Why?
|
| Fluorouracil | 1 | 2012 | 55 | 0.100 |
Why?
|
| Interferon Regulatory Factors | 1 | 2012 | 39 | 0.100 |
Why?
|
| Protein Kinases | 1 | 2013 | 139 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 53 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2012 | 100 | 0.100 |
Why?
|
| PPAR gamma | 1 | 2012 | 73 | 0.100 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 134 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 203 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 193 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2011 | 58 | 0.090 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 160 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2012 | 306 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2012 | 343 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 292 | 0.090 |
Why?
|
| Dasatinib | 1 | 2010 | 3 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 525 | 0.090 |
Why?
|
| Trans-Activators | 1 | 2012 | 298 | 0.090 |
Why?
|
| Cell Survival | 1 | 2012 | 558 | 0.090 |
Why?
|
| Harringtonines | 1 | 2010 | 1 | 0.090 |
Why?
|
| Philadelphia Chromosome | 1 | 2010 | 3 | 0.090 |
Why?
|
| Thiazoles | 1 | 2010 | 46 | 0.090 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2010 | 8 | 0.090 |
Why?
|
| Cell Transplantation | 1 | 2010 | 39 | 0.080 |
Why?
|
| Disease Progression | 2 | 2014 | 1053 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 436 | 0.080 |
Why?
|
| Imidazoles | 1 | 2010 | 83 | 0.080 |
Why?
|
| Survival Rate | 1 | 2012 | 793 | 0.080 |
Why?
|
| Medical Oncology | 1 | 2010 | 57 | 0.080 |
Why?
|
| Point Mutation | 1 | 2010 | 161 | 0.080 |
Why?
|
| Benzodiazepines | 1 | 2010 | 99 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 484 | 0.080 |
Why?
|
| Hedgehog Proteins | 1 | 2010 | 112 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 232 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2009 | 196 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 666 | 0.070 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 233 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 1142 | 0.070 |
Why?
|
| Biomarkers | 1 | 2012 | 1214 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1465 | 0.070 |
Why?
|
| Cell Line | 1 | 2010 | 2008 | 0.060 |
Why?
|
| Models, Biological | 1 | 2010 | 1142 | 0.060 |
Why?
|
| Time Factors | 1 | 2012 | 3621 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2019 | 860 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2022 | 150 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2022 | 282 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 419 | 0.040 |
Why?
|
| bcl-Associated Death Protein | 1 | 2019 | 10 | 0.040 |
Why?
|
| Leukemia, Experimental | 1 | 2019 | 19 | 0.040 |
Why?
|
| STAT Transcription Factors | 1 | 2019 | 18 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 82 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2022 | 1298 | 0.030 |
Why?
|
| raf Kinases | 1 | 2014 | 4 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2014 | 24 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2014 | 52 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 71 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 2014 | 98 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 193 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1387 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 808 | 0.020 |
Why?
|
| Male | 1 | 2010 | 27951 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 1224 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 855 | 0.020 |
Why?
|